CUSIP No. 85788D100
|
UNITED
STATES
|
|
|
SECURITIES
AND EXCHANGE COMMISSION
|
|
|
Washington,
D.C. 20549
|
|
Under the Securities Exchange Act of
1934
(Amendment No. 5)*
Stealth
BioTherapeutics Corp
(Name of Issuer)
Ordinary
Shares, par value $0.0003 per share
(Title of Class of Securities)
85788D100
(CUSIP Number)
Morningside Venture (I) Investments
Limited
C/O THC Management Services S.A.M.,
2nd Floor,
Le Prince De Galles
3-5 Avenue DesCitronniers
Monaco, MC 98000
011-377-97-97-47-37
with a copy to:
Morningside Technology Advisory, LLC
Attn: Stephanie O’Brien, Esq.
1188 Centre Street
Newton
Centre, MA 02459
(Name, Address and Telephone Number of
Person
Authorized to Receive Notices and Communications)
December 31,
2020
(Date of Event Which Requires Filing of
this Statement)
If
the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule
13D, and is filing this schedule because of §§240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box.
o
Note:
Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See Rule 13d-7
for other parties to whom copies are to be sent.
* The
remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the
subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in
a prior cover page.
The information required on the remainder of this
cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act
of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other
provisions of the Act (however, see the Notes)
CUSIP No. 85788D100
|
(1)
|
Names
of Reporting Persons
Morningside Venture (I) Investments Limited
|
|
|
(2)
|
Check the Appropriate
Box if a Member of a Group (See Instructions)
|
|
|
(a)
|
x
|
|
|
(b)
|
o
|
|
|
(3)
|
SEC
Use Only
|
|
|
(4)
|
Source
of Funds (See Instructions)
WC
|
|
|
(5)
|
Check
if Disclosure of Legal Proceedings Is Required Pursuant to Items 2(d) or 2(e) o
|
|
|
(6)
|
Citizenship
or Place of Organization
British Virgin Islands
|
|
Number
of
Shares
Beneficially
Owned by
Each
Reporting
Person With:
|
(7)
|
Sole
Voting Power
0
|
|
(8)
|
Shared
Voting Power
465,713,861 (1)
|
|
(9)
|
Sole
Dispositive Power
0
|
|
(10)
|
Shared
Dispositive Power
465,713,861 (1)
|
|
|
(11)
|
Aggregate
Amount Beneficially Owned by Each Reporting Person
465,713,861 (1)
|
|
|
(12)
|
Check
if the Aggregate Amount in Row (11) Excludes Certain Shares (See Instructions) o
|
|
|
(13)
|
Percent
of Class Represented by Amount in Row (11)
70.0% (2)
|
|
|
(14)
|
Type
of Reporting Person (See Instructions)
CO
|
|
|
|
|
|
|
(1) The Ordinary Shares beneficially owned may be exchanged
into American Depositary Shares on a twelve-for-one basis.
(2) Based on 665,214,754 Ordinary Shares outstanding as
of February 11, 2021 as reported in the Issuer’s prospectus supplement filed with the Securities and Exchange Commission
(the “SEC”) on February 11, 2021 pursuant to Rule 424(b)(5) of the Securities Act of 1933.
CUSIP No. 85788D100
|
(1)
|
Names
of Reporting Persons
Frances Anne Elizabeth Richard
|
|
|
(2)
|
Check the Appropriate
Box if a Member of a Group (See Instructions)
|
|
|
(a)
|
x
|
|
|
(b)
|
o
|
|
|
(3)
|
SEC
Use Only
|
|
|
(4)
|
Source
of Funds (See Instructions)
AF
|
|
|
(5)
|
Check
if Disclosure of Legal Proceedings Is Required Pursuant to Items 2(d) or 2(e) o
|
|
|
(6)
|
Citizenship
or Place of Organization
United Kingdom
|
|
Number
of
Shares
Beneficially
Owned by
Each
Reporting
Person With:
|
(7)
|
Sole
Voting Power
0
|
|
(8)
|
Shared
Voting Power
465,713,861 (1)
|
|
(9)
|
Sole
Dispositive Power
0
|
|
(10)
|
Shared
Dispositive Power
465,713,861 (1)
|
|
|
(11)
|
Aggregate
Amount Beneficially Owned by Each Reporting Person
465,713,861 (1)
|
|
|
(12)
|
Check
if the Aggregate Amount in Row (11) Excludes Certain Shares (See Instructions) o
|
|
|
(13)
|
Percent
of Class Represented by Amount in Row (11)
70.0% (2)
|
|
|
(14)
|
Type
of Reporting Person (See Instructions)
IN
|
|
|
|
|
|
|
(1) The Ordinary Shares beneficially owned may be exchanged
into American Depositary Shares on a twelve-for-one basis.
(2) Based on 665,214,754 Ordinary Shares outstanding as
of February 11, 2021 as reported in the Issuer’s prospectus supplement filed with the Securities and Exchange Commission
(the “SEC”) on February 11, 2021 pursuant to Rule 424(b)(5) of the Securities Act of 1933.
CUSIP No. 85788D100
|
(1)
|
Names
of Reporting Persons
Jill Marie Franklin
|
|
|
(2)
|
Check the Appropriate
Box if a Member of a Group (See Instructions)
|
|
|
(a)
|
x
|
|
|
(b)
|
o
|
|
|
(3)
|
SEC
Use Only
|
|
|
(4)
|
Source
of Funds (See Instructions)
AF
|
|
|
(5)
|
Check
if Disclosure of Legal Proceedings Is Required Pursuant to Items 2(d) or 2(e) o
|
|
|
(6)
|
Citizenship
or Place of Organization
United Kingdom
|
|
Number
of
Shares
Beneficially
Owned by
Each
Reporting
Person With:
|
(7)
|
Sole
Voting Power
0
|
|
(8)
|
Shared
Voting Power
465,713,861 (1)
|
|
(9)
|
Sole
Dispositive Power
0
|
|
(10)
|
Shared
Dispositive Power
465,713,861 (1)
|
|
|
(11)
|
Aggregate
Amount Beneficially Owned by Each Reporting Person
465,713,861 (1)
|
|
|
(12)
|
Check
if the Aggregate Amount in Row (11) Excludes Certain Shares (See Instructions) o
|
|
|
(13)
|
Percent
of Class Represented by Amount in Row (11)
70.0% (2)
|
|
|
(14)
|
Type
of Reporting Person (See Instructions)
IN
|
|
|
|
|
|
|
(1) The Ordinary Shares beneficially owned may be exchanged
into American Depositary Shares on a twelve-for-one basis.
(2) Based on 665,214,754 Ordinary Shares outstanding as
of February 11, 2021 as reported in the Issuer’s prospectus supplement filed with the Securities and Exchange Commission
(the “SEC”) on February 11, 2021 pursuant to Rule 424(b)(5) of the Securities Act of 1933.
CUSIP No. 85788D100
|
(1)
|
Names
of Reporting Persons
Peter Stuart Allenby Edwards
|
|
|
(2)
|
Check the Appropriate
Box if a Member of a Group (See Instructions)
|
|
|
(a)
|
x
|
|
|
(b)
|
o
|
|
|
(3)
|
SEC
Use Only
|
|
|
(4)
|
Source
of Funds (See Instructions)
AF
|
|
|
(5)
|
Check
if Disclosure of Legal Proceedings Is Required Pursuant to Items 2(d) or 2(e) o
|
|
|
(6)
|
Citizenship
or Place of Organization
United Kingdom
|
|
Number
of
Shares
Beneficially
Owned by
Each
Reporting
Person With:
|
(7)
|
Sole
Voting Power
0
|
|
(8)
|
Shared
Voting Power
465,713,861 (1)
|
|
(9)
|
Sole
Dispositive Power
0
|
|
(10)
|
Shared
Dispositive Power
465,713,861 (1)
|
|
|
(11)
|
Aggregate
Amount Beneficially Owned by Each Reporting Person
465,713,861 (1)
|
|
|
(12)
|
Check
if the Aggregate Amount in Row (11) Excludes Certain Shares (See Instructions) o
|
|
|
(13)
|
Percent
of Class Represented by Amount in Row (11)
70.0% (2)
|
|
|
(14)
|
Type
of Reporting Person (See Instructions)
IN
|
|
|
|
|
|
|
(1) The Ordinary Shares beneficially owned may be exchanged
into American Depositary Shares on a twelve-for-one basis.
(2) Based on 665,214,754 Ordinary Shares outstanding as
of February 11, 2021 as reported in the Issuer’s prospectus supplement filed with the Securities and Exchange Commission
(the “SEC”) on February 11, 2021 pursuant to Rule 424(b)(5) of the Securities Act of 1933.
CUSIP No. 85788D100
|
(1)
|
Names
of Reporting Persons
Cheung Ka Ho
|
|
|
(2)
|
Check the Appropriate
Box if a Member of a Group (See Instructions)
|
|
|
(a)
|
x
|
|
|
(b)
|
o
|
|
|
(3)
|
SEC
Use Only
|
|
|
(4)
|
Source
of Funds (See Instructions)
AF
|
|
|
(5)
|
Check
if Disclosure of Legal Proceedings Is Required Pursuant to Items 2(d) or 2(e) o
|
|
|
(6)
|
Citizenship
or Place of Organization
Hong Kong
|
|
Number
of
Shares
Beneficially
Owned by
Each
Reporting
Person With:
|
(7)
|
Sole
Voting Power
0
|
|
(8)
|
Shared
Voting Power
465,713,861 (1)
|
|
(9)
|
Sole
Dispositive Power
0
|
|
(10)
|
Shared
Dispositive Power
465,713,861 (1)
|
|
|
(11)
|
Aggregate
Amount Beneficially Owned by Each Reporting Person
465,713,861 (1)
|
|
|
(12)
|
Check
if the Aggregate Amount in Row (11) Excludes Certain Shares (See Instructions) o
|
|
|
(13)
|
Percent
of Class Represented by Amount in Row (11)
70.0% (2)
|
|
|
(14)
|
Type
of Reporting Person (See Instructions)
IN
|
|
|
|
|
|
|
(1) The Ordinary Shares beneficially owned may be exchanged
into American Depositary Shares on a twelve-for-one basis.
(2) Based on 665,214,754 Ordinary Shares outstanding as
of February 11, 2021 as reported in the Issuer’s prospectus supplement filed with the Securities and Exchange Commission
(the “SEC”) on February 11, 2021 pursuant to Rule 424(b)(5) of the Securities Act of 1933.
CUSIP No. 85788D100
|
(1)
|
Names
of Reporting Persons
Equal Talent Investments Limited
|
|
|
(2)
|
Check the Appropriate
Box if a Member of a Group (See Instructions)
|
|
|
(a)
|
x
|
|
|
(b)
|
o
|
|
|
(3)
|
SEC
Use Only
|
|
|
(4)
|
Source
of Funds (See Instructions)
WC
|
|
|
(5)
|
Check
if Disclosure of Legal Proceedings Is Required Pursuant to Items 2(d) or 2(e) o
|
|
|
(6)
|
Citizenship
or Place of Organization
British Virgin Islands
|
|
Number
of
Shares
Beneficially
Owned by
Each
Reporting
Person With:
|
(7)
|
Sole
Voting Power
19,533,720 (1)
|
|
(8)
|
Shared
Voting Power
0
|
|
(9)
|
Sole
Dispositive Power
19,533,720 (1)
|
|
(10)
|
Shared
Dispositive Power
0
|
|
|
(11)
|
Aggregate
Amount Beneficially Owned by Each Reporting Person
19,533,720 (1)
|
|
|
(12)
|
Check
if the Aggregate Amount in Row (11) Excludes Certain Shares (See Instructions) o
|
|
|
(13)
|
Percent
of Class Represented by Amount in Row (11)
2.9% (2)
|
|
|
(14)
|
Type
of Reporting Person (See Instructions)
CO
|
|
|
|
|
|
|
(1) The Ordinary Shares beneficially owned may be exchanged
into American Depositary Shares on a twelve-for-one basis.
(2) Based on 665,214,754 Ordinary Shares outstanding as
of February 11, 2021 as reported in the Issuer’s prospectus supplement filed with the Securities and Exchange Commission
(the “SEC”) on February 11, 2021 pursuant to Rule 424(b)(5) of the Securities Act of 1933.
CUSIP No. 85788D100
|
(1)
|
Names
of Reporting Persons
Season Pioneer Investments Limited
|
|
|
(2)
|
Check the Appropriate
Box if a Member of a Group (See Instructions)
|
|
|
(a)
|
x
|
|
|
(b)
|
o
|
|
|
(3)
|
SEC
Use Only
|
|
|
(4)
|
Source
of Funds (See Instructions)
WC
|
|
|
(5)
|
Check
if Disclosure of Legal Proceedings Is Required Pursuant to Items 2(d) or 2(e) o
|
|
|
(6)
|
Citizenship
or Place of Organization
British Virgin Islands
|
|
Number
of
Shares
Beneficially
Owned by
Each
Reporting
Person With:
|
(7)
|
Sole
Voting Power
39,066,276 (1)
|
|
(8)
|
Shared
Voting Power
0
|
|
(9)
|
Sole
Dispositive Power
39,066,276 (1)
|
|
(10)
|
Shared
Dispositive Power
0
|
|
|
(11)
|
Aggregate
Amount Beneficially Owned by Each Reporting Person
39,066,276 (1)
|
|
|
(12)
|
Check
if the Aggregate Amount in Row (11) Excludes Certain Shares (See Instructions) o
|
|
|
(13)
|
Percent
of Class Represented by Amount in Row (11)
5.9% (2)
|
|
|
(14)
|
Type
of Reporting Person (See Instructions)
CO
|
|
|
|
|
|
|
(1) The Ordinary Shares beneficially owned may be exchanged
into American Depositary Shares on a twelve-for-one basis.
(2) Based on 665,214,754 Ordinary Shares outstanding as
of February 11, 2021 as reported in the Issuer’s prospectus supplement filed with the Securities and Exchange Commission
(the “SEC”) on February 11, 2021 pursuant to Rule 424(b)(5) of the Securities Act of 1933.
CUSIP No. 85788D100
|
(1)
|
Names
of Reporting Persons
Suk Ying Pauli Ng
|
|
|
(2)
|
Check the Appropriate
Box if a Member of a Group (See Instructions)
|
|
|
(a)
|
x
|
|
|
(b)
|
o
|
|
|
(3)
|
SEC
Use Only
|
|
|
(4)
|
Source
of Funds (See Instructions)
AF
|
|
|
(5)
|
Check
if Disclosure of Legal Proceedings Is Required Pursuant to Items 2(d) or 2(e) o
|
|
|
(6)
|
Citizenship
or Place of Organization
Hong Kong
|
|
Number
of
Shares
Beneficially
Owned by
Each
Reporting
Person With:
|
(7)
|
Sole
Voting Power
58,599,996 (1)
|
|
(8)
|
Shared
Voting Power
0
|
|
(9)
|
Sole
Dispositive Power
58,599,996 (1)
|
|
(10)
|
Shared
Dispositive Power
0
|
|
|
(11)
|
Aggregate
Amount Beneficially Owned by Each Reporting Person
58,599,996 (1)
|
|
|
(12)
|
Check
if the Aggregate Amount in Row (11) Excludes Certain Shares (See Instructions) o
|
|
|
(13)
|
Percent
of Class Represented by Amount in Row (11)
8.8% (2)
|
|
|
(14)
|
Type
of Reporting Person (See Instructions)
IN
|
|
|
|
|
|
|
(1) The Ordinary Shares beneficially owned may be exchanged
into American Depositary Shares on a twelve-for-one basis.
(2) Based on 665,214,754 Ordinary Shares outstanding as
of February 11, 2021 as reported in the Issuer’s prospectus supplement filed with the Securities and Exchange Commission
(the “SEC”) on February 11, 2021 pursuant to Rule 424(b)(5) of the Securities Act of 1933.
CUSIP No. 85788D100
|
Item
1.
|
Security and Issuer.
|
This Amendment No. 5 (“Amendment No. 5”)
amends the Schedule 13D filed with the SEC on February 28, 2019 (the “Original Schedule 13D”), which Original
Schedule 13D was amended by Amendment No. 1 to the Original Schedule 13D filed on March 22, 2019 (“Amendment No. 1”),
Amendment No. 2 to the Original Schedule 13D filed on May 24, 2019 (“Amendment No. 2”), Amendment No. 3
to the Original Schedule 13D filed on April 15, 2020 (“Amendment No. 3”), Amendment No. 4 to the
Original Schedule 13D filed on October 30, 2020 (“Amendment No. 4”), and together with the Original Schedule
13D, Amendment No. 1, Amendment No. 2, Amendment No. 3, Amendment No. 4, and Amendment No. 5, (the “Amended
Filing”) relates to the Reporting Persons’ (as defined in Item 2 below) beneficial ownership interest in the ordinary
shares, par value $0.0003 per share (the “Ordinary Shares”), of Stealth BioTherapeutics Corp, a Cayman Islands company
(the “Issuer”), which conducts its operations in the United States through Stealth BioTherapeutics, Inc., a Delaware
corporation (“Stealth Delaware”). The address of the principal executive office of Stealth Delaware is 275 Grove Street,
Suite 3-107, Newton, Massachusetts 02466. Information given in response to each item shall be deemed incorporated by reference
in all other items, as applicable.
Except as otherwise described herein, the information
contained in the Amended Filing remains in effect. Capitalized terms used but not defined in this Amendment shall have the respective
meanings set forth with respect thereto in the Amended Filing.
|
Item
2.
|
Identity and Background.
|
|
(a)
|
This statement is filed by:
|
|
(i)
|
Morningside Venture (I) Investments Limited, a British
Virgin Islands exempted company (“MVIL”), with respect to the Ordinary Shares directly and beneficially owned by it;
|
|
(ii)
|
Frances Anne Elizabeth Richard, with respect to the Ordinary
Shares beneficially owned by her as a result of her position as a director with MVIL;
|
|
(iii)
|
Jill Marie Franklin, with respect to the Ordinary Shares
beneficially owned by her as a result of her position as a director with MVIL;
|
|
(iv)
|
Peter Stuart Allenby Edwards, with respect to the Ordinary
Shares beneficially owned by him as a result of his position as a director with MVIL;
|
|
(v)
|
Cheung Ka Ho, with respect to the Ordinary Shares beneficially
owned by him as a result of his position as a director with MVIL;
|
|
(vi)
|
Equal Talent Investments Limited, a British Virgin Islands
exempted company (“ETIL”), with respect to the Ordinary Shares beneficially owned by it;
|
|
(vii)
|
Season Pioneer Investments Limited, a British Virgin
Islands exempted company (“SPIL”), with respect to the Ordinary Shares beneficially owned by it; and
|
|
(viii)
|
Suk Ying Pauli Ng, with respect to the Ordinary Shares
beneficially owned by her as a result of her positions as a director with ETIL and as a director with SPIL.
|
Each of the foregoing is referred
to as a “Reporting Person” and collectively as the “Reporting Persons.”
Frances Anne Elizabeth Richard, Jill Marie Franklin,
Peter Stuart Allenby Edwards and Cheung Ka Ho, are the directors of MVIL and share voting and dispositive power with respect to
the securities held by MVIL. Ms. Richard, Ms. Franklin, Mr. Edwards and Mr. Cheung each disclaim beneficial
ownership of the securities owned directly by MVIL. MVIL disclaims beneficial ownership of the securities owned directly
by ETIL and SPIL. MVIL is ultimately wholly beneficially owned by a family trust established by Madam Chan Tan Ching Fen.
CUSIP No. 85788D100
Suk Ying Pauli Ng is the sole director of ETIL and
has sole voting and dispositive power with respect to the securities held by ETIL. Ms. Ng disclaims beneficial ownership
of the securities owned directly by ETIL. ETIL disclaims beneficial ownership of the securities owned directly by MVIL and
SPIL. ETIL is ultimately wholly beneficially owned by a trust over which Peter Stuart Allenby Edwards has sole authority
to remove the trustee.
Suk Ying Pauli Ng is the sole director of SPIL and
has sole voting and dispositive power with respect to the securities held by SPIL. Ms. Ng disclaims beneficial ownership
of the securities owned directly by SPIL. SPIL disclaims beneficial ownership of the securities owned directly by MVIL and
ETIL. SPIL is ultimately wholly beneficially owned by a trust over which Peter Stuart Allenby Edwards has sole authority
to remove the trustee.
|
(b)
|
The business address of each of the Reporting Persons
is:
|
|
(i)
|
With respect to MVIL, Ms. Richard, Ms. Franklin,
Mr. Edwards and Mr. Cheung:
|
c/o THC Management Services S.A.M.,
2nd Floor, Le Prince De Galles
3-5 Avenue Des Citronniers
MC 98000, Monaco
With copies to:
Morningside Technology Advisory, LLC
Attn: Stephanie O’Brien, Esq.
1188 Centre Street
Newton Centre, MA 02459
Springfield Financial Advisory Limited
Attn: Alice Li/Makim Ma
22nd Floor Hang Lung Centre
2-20 Paterson Street
Causeway Bay, Hong Kong
|
(ii)
|
With respect to ETIL and Ms. Ng:
|
c/o THC Management Services S.A.M.,
2nd Floor, Le Prince De Galles
3-5 Avenue Des Citronniers
MC 98000, Monaco
With copies to:
Morningside Technology Advisory, LLC
Attn: Stephanie O’Brien, Esq.
1188 Centre Street
Newton Centre, MA 02459
Springfield Financial Advisory Limited
Attn: Alice Li/Makim Ma
22nd Floor Hang Lung Centre
2-20 Paterson Street
Causeway Bay, Hong Kong
CUSIP No. 85788D100
|
(iii)
|
With respect to SPIL and Ms. Ng:
|
c/o THC Management Services S.A.M.,
2nd Floor, Le Prince De Galles
3-5 Avenue Des Citronniers
MC 98000, Monaco
With copies to:
Morningside Technology Advisory, LLC
Attn: Stephanie O’Brien, Esq.
1188 Centre Street
Newton Centre, MA 02459
Springfield Financial Advisory Limited
Attn: Alice Li/Makim Ma
22nd Floor Hang Lung Centre
2-20 Paterson Street
Causeway Bay, Hong Kong
|
(c)
|
The present principal business of MVIL, Ms. Richard,
Ms. Franklin, Mr. Edwards, Mr. Cheung, ETIL, SPIL and Ms. Ng is the venture capital and private equity investment
business.
|
|
(d)
|
No Reporting Person, during the last five years, has
been convicted in a criminal proceeding (excluding traffic violations or similar misdemeanors).
|
|
(e)
|
No Reporting Person, during the last five years, has
been a party to a civil proceeding of a judicial or administrative body of competent jurisdiction and as a result of such proceeding
was or is subject to a judgment, decree or final order enjoining future violations of, or prohibiting or mandating activities
subject to, federal or state securities laws or finding any violation with respect to such laws.
|
|
(f)
|
Citizenship of the Reporting Persons is as set forth
below:
|
MVIL
|
|
British Virgin Islands
|
Ms. Richard
|
|
United Kingdom
|
Ms. Franklin
|
|
United Kingdom
|
Mr. Edwards
|
|
United Kingdom
|
Mr. Cheung
|
|
Hong Kong
|
ETIL
|
|
British Virgin Islands
|
SPIL
|
|
British Virgin Islands
|
Ms. Ng
|
|
Hong Kong
|
|
Item
3.
|
Source and Amount of Funds or Other Consideration.
|
No changes, except as set forth below.
On October 30, 2020, MVIL acquired a warrant
exercisable for 46,153,846 ordinary shares of the Issuer at an exercise price of $0.13 per share (the “Warrants”).
The Warrants have a three-year term. The Warrants were acquired in connection a development funding agreement between MVIL and
the Issuer dated as of October 30, 2020 under which MVIL agreed to provide funding to the Issuer in connection with the development
of one of its product candidates (the “Development Funding Agreement”).
|
Item
4.
|
Purpose of Transaction.
|
No changes.
CUSIP No. 85788D100
|
Item
5.
|
Interest in Securities of the Issuer.
|
No changes except as described below.
The aggregate percentage of Ordinary Shares reported
beneficially owned by each person named herein is determined in accordance with SEC rules and is based upon 665,214,754 of
the Issuer’s Ordinary Shares outstanding. The applicable SEC rules generally attribute beneficial ownership of securities
to persons who possess sole or shared voting power or investment power with respect to those securities.
|
A.
|
Morningside Venture (I) Investments Limited
|
|
(a)
|
As of the date hereof, MVIL beneficially owns 465,713,861
Ordinary Shares, representing a beneficial ownership of approximately 70.0% of the Ordinary Shares. MVIL directly holds
418,960,015 ordinary shares, including ordinary shares represented by American Depositary Shares (“ADSs”). MVIL has
the right to acquire (i) 46,153,846 ordinary shares upon exercise of the Warrants and (ii) 600,000 ordinary shares upon
the exercise of an option to purchase ordinary shares.
|
(b)
|
1. Sole power to vote or direct vote:
|
|
-0-
|
|
|
2. Shared power to vote or direct vote:
|
|
465,713,861
|
|
|
3. Sole power to dispose or direct the disposition:
|
|
-0-
|
|
|
4. Shared power to dispose or direct the disposition:
|
|
465,713,861
|
|
|
B.
|
Frances Anne Elizabeth Richard
|
|
(a)
|
As of the date hereof, Ms. Richard beneficially
owns 465,713,861 Ordinary Shares, representing a beneficial ownership of approximately 70.0% of the Ordinary Shares. MVIL
directly holds 418,960,015 ordinary shares, including ordinary shares represented by American Depositary Shares (“ADSs”).
MVIL has the right to acquire (i) 46,153,846 ordinary shares upon exercise of the Warrants and (ii) 600,000 ordinary
shares upon the exercise of an option to purchase ordinary shares.
|
(b)
|
1. Sole power to vote or direct vote:
|
|
-0-
|
|
|
2. Shared power to vote or direct vote:
|
|
465,713,861
|
|
|
3. Sole power to dispose or direct the disposition:
|
|
-0-
|
|
|
4. Shared power to dispose or direct the disposition:
|
|
465,713,861
|
|
|
(a)
|
As of the date hereof, Ms. Franklin beneficially
owns 465,713,861 Ordinary Shares, representing a beneficial ownership of approximately 70.0% of the Ordinary Shares. MVIL
directly holds 418,960,015 ordinary shares, including ordinary shares represented by American Depositary Shares (“ADSs”).
MVIL has the right to acquire (i) 46,153,846 ordinary shares upon exercise of the Warrants and (ii) 600,000 ordinary
shares upon the exercise of an option to purchase ordinary shares.
|
(b)
|
1. Sole power to vote or direct vote:
|
|
-0-
|
|
|
2. Shared power to vote or direct vote:
|
|
465,713,861
|
|
|
3. Sole power to dispose or direct the disposition:
|
|
-0-
|
|
|
4. Shared power to dispose or direct the disposition:
|
|
465,713,861
|
|
CUSIP No. 85788D100
|
D.
|
Peter Stuart Allenby Edwards
|
|
(a)
|
As of the date hereof, Mr. Edwards beneficially
owns 465,713,861 Ordinary Shares, representing a beneficial ownership of approximately 70.0% of the Ordinary Shares. MVIL
directly holds 418,960,015 ordinary shares, including ordinary shares represented by American Depositary Shares (“ADSs”).
MVIL has the right to acquire (i) 46,153,846 ordinary shares upon exercise of the Warrants and (ii) 600,000 ordinary
shares upon the exercise of an option to purchase ordinary shares.
|
(b)
|
1. Sole power to vote or direct vote:
|
|
-0-
|
|
|
2. Shared power to vote or direct vote:
|
|
465,713,861
|
|
|
3. Sole power to dispose or direct the disposition:
|
|
-0-
|
|
|
4. Shared power to dispose or direct the disposition:
|
|
465,713,861
|
|
|
(a)
|
As of the date hereof, Mr. Cheung beneficially owns
465,713,861 Ordinary Shares, representing a beneficial ownership of approximately 70.0% of the Ordinary Shares. MVIL directly
holds 418,960,015 ordinary shares, including ordinary shares represented by American Depositary Shares (“ADSs”). MVIL
has the right to acquire (i) 46,153,846 ordinary shares upon exercise of the Warrants and (ii) 600,000 ordinary shares
upon the exercise of an option to purchase ordinary shares.
|
(b)
|
1. Sole power to vote or direct vote:
|
|
-0-
|
|
|
2. Shared power to vote or direct vote:
|
|
465,713,861
|
|
|
3. Sole power to dispose or direct the disposition:
|
|
-0-
|
|
|
4. Shared power to dispose or direct the disposition:
|
|
465,713,861
|
|
|
F.
|
Equal Talent Investments Limited
|
|
(a)
|
As of the date hereof, ETIL holds 1,627,810 ADSs, representing
19,533,720 Ordinary Shares and a beneficial ownership of approximately 2.9% of the Ordinary Shares. All such ADSs are directly
held by ETIL.
|
(b)
|
1. Sole power to vote or direct vote:
|
|
19,533,720
|
|
|
2. Shared power to vote or direct vote:
|
|
-0-
|
|
|
3. Sole power to dispose or direct the disposition:
|
|
19,533,720
|
|
|
4. Shared power to dispose or direct the disposition:
|
|
-0-
|
|
|
G.
|
Season Pioneer Investments Limited
|
|
(a)
|
As of the date hereof, SPIL holds 3,255,523 ADSs, representing
39,066,276 Ordinary Shares and a beneficial ownership of approximately 5.9% of the Ordinary Shares. All such ADSs are directly
held by SPIL.
|
(b)
|
1. Sole power to vote or direct vote:
|
|
39,066,276
|
|
|
2. Shared power to vote or direct vote:
|
|
-0-
|
|
|
3. Sole power to dispose or direct the disposition:
|
|
39,066,276
|
|
|
4. Shared power to dispose or direct the disposition:
|
|
-0-
|
|
|
(a)
|
As of the date hereof, Ms. Ng beneficially owns
58,599,996 Ordinary Shares, representing a beneficial ownership of approximately 8.8% of the Ordinary Shares. 19,533,720
of such shares are beneficially owned by ETIL, which directly holds 1,627,810 ADSs and 39,066,276 of such shares are beneficially
owned by SPIL, which directly holds 3,255,523 ADSs.
|
(b)
|
1. Sole power to vote or direct vote:
|
|
58,599,996
|
|
|
2. Shared power to vote or direct vote:
|
|
-0-
|
|
|
3. Sole power to dispose or direct the disposition:
|
|
58,599,996
|
|
|
4. Shared power to dispose or direct the disposition:
|
|
-0-
|
|
CUSIP No. 85788D100
|
Item
6.
|
Contracts, Arrangements, Understandings or Relationships
with Respect to Securities of the Issuer.
|
The lock-up agreement described in the Original Schedule
13D and entered into in connection with Issuer’s initial public offering has expired by its terms.
If MVIL commits to providing additional funding to
the Issuer pursuant to the Development Funding Agreement, the Development Funding Agreement requires the Issuer to issue additional
warrants to MVIL with the same terms as the Warrants. Any additional warrants will be exercisable for a number of ordinary shares
equal to the quotient of (a) 30% of the amount of the additional commitment from MVIL divided by (b) 115% of the implied
price of the Issuer’s ordinary shares on the date of issuance of the additional warrants based upon the price of Issuer’s
ADSs as listed on the Nasdaq Global Market.
|
Item
7.
|
Material to be Filed as Exhibits.
|
No changes except as described below.
The following documents are filed as Exhibits to this
statement:
Exhibit
Number
|
|
Exhibit Description
|
|
|
|
99.1
|
|
Joint Filing Agreement
|
CUSIP No. 85788D100
SIGNATURES
After reasonable inquiry and to the best of my knowledge and
belief, we certify that the information set forth in this statement is true, complete and correct. We also hereby agree to file
this statement jointly pursuant to the Agreement listed on Exhibit 99.1 hereto.
Dated: February 16, 2021
For and on behalf of
MORNINGSIDE VENTURE (I) INVESTMENTS LIMITED
|
|
|
|
By:
|
/s/ Frances Anne Elizabeth Richard
|
|
|
Frances Anne Elizabeth Richard, Director
|
|
|
|
/s/ Frances Anne Elizabeth Richard
|
|
Frances Anne Elizabeth Richard
|
|
|
|
/s/ Jill Marie Franklin
|
|
Jill Marie Franklin
|
|
|
|
/s/ Peter Stuart Allenby Edwards
|
|
Peter Stuart Allenby Edwards
|
|
|
|
/s/ Cheung Ka Ho
|
|
Cheung Ka Ho
|
|
|
|
For and on behalf of
|
|
|
|
EQUAL TALENT INVESTMENTS LIMITED
|
|
|
|
By:
|
/s/ Suk Ying Pauli Ng
|
|
|
Suk Ying Pauli Ng, Director
|
|
|
|
/s/ Suk Ying Pauli Ng
|
|
Suk Ying Pauli Ng
|
|
|
|
For and on behalf of
|
|
|
|
SEASON PIONEER INVESTMENTS LIMITED
|
|
|
|
By:
|
/s/ Suk Ying Pauli Ng
|
|
|
Suk Ying Pauli Ng, Director
|
|
|
|
/s/ Suk Ying Pauli Ng
|
|
Suk Ying Pauli Ng
|
|
CUSIP No. 85788D100
Exhibit 99.1
JOINT
FILING AGREEMENT
The undersigned, being duly authorized
thereunder, hereby execute this agreement as an exhibit to this Schedule 13D to evidence the agreement of the below-named parties,
in accordance with the rules promulgated pursuant to the Securities Exchange Act of 1934, to file this Schedule jointly on
behalf of each such party.
MORNINGSIDE VENTURE (I) INVESTMENTS LIMITED
|
|
|
|
By:
|
/s/ Frances Anne Elizabeth Richard
|
|
|
Frances Anne Elizabeth Richard, Director
|
|
|
|
/s/ Frances Anne Elizabeth Richard
|
|
Frances Anne Elizabeth Richard
|
|
|
|
/s/ Jill Marie Franklin
|
|
Jill Marie Franklin
|
|
|
|
/s/ Peter Stuart Allenby Edwards
|
|
Peter Stuart Allenby Edwards
|
|
|
|
/s/ Cheung Ka Ho
|
|
Cheung Ka Ho
|
|
|
|
For and on behalf of
|
|
|
|
EQUAL TALENT INVESTMENTS LIMITED
|
|
|
|
By:
|
/s/ Suk Ying Pauli Ng
|
|
|
Suk Ying Pauli Ng, Director
|
|
|
|
/s/ Suk Ying Pauli Ng
|
|
Suk Ying Pauli Ng
|
|
|
|
For and on behalf of
|
|
|
|
SEASON PIONEER INVESTMENTS LIMITED
|
|
|
|
By:
|
/s/ Suk Ying Pauli Ng
|
|
|
Suk Ying Pauli Ng, Director
|
|
|
|
/s/ Suk Ying Pauli Ng
|
|
Suk Ying Pauli Ng
|
|